{"1":[["CCG","provided","companies with capital commitments and funding"],["ere are the extracted triplets:\n\n<Since its inception","in","June 2009"],["Terren Peizer","amount of funding","$1.2 Billion"]],"2":[["<Acuitas Group","owns","100% of NeurMedix, Inc."],["<Acuitas Group","owns","72% of Catasys, Inc."],["ere are the extracted triplets:\n\n<Acuitas Group","owns","Crede Capital"]],"3":[["Terren Peizer","company","Crede Capital Group"],["Terren Peizer","company","Acuitas"],["Terren Peizer","company","Catasys"],["ere are the triplets extracted from the text:\n\n<Peizer","Founder","Chairman"],["Terren Peizer","position","CEO"]],"4":[["<22nd Century Group, Inc.","commercializing","bio-plant technology"],["ere are the extracted triplets:\n\n<Crede Capital","developed expertise in","bioscience"],["<Terren Peizer","became largest shareholder in","22nd Century Group, Inc."]],"6":[["<China National Tobacco Company","monopoly in","China"],["<Terren Peizer","partnered with","China National Tobacco Company"],["ere are the extracted triplets:\n\n<Terren Peizer","formed a JV with","22nd Century"]],"7":[["--------------------\n<Text: Terren Peizer:  China represents over 50% of the worldwide tobacco market.>\nTriplets:<Terren Peizer","topic","China"]]}